Earnings
1933 Industries Reports Second Quarter 2026 Financial Results
1933 Industries Posts Q2 Revenue Slide as Cost Cuts Mask Nevada Cannabis Headwinds
Executive Summary
- 1933 Industries reported Q2 fiscal 2026 revenue of C$7.9M, a 6% year-over-year decline from C$8.4M.
- Gross profit contracted to C$1.9M, compressing the gross margin to 24% from 34% in the prior year period.
- Operating expenses were aggressively reduced to C$2.1M from C$3.7M YoY, driven by lower license taxes and insurance costs.
- The company posted a net loss of C$0.2M, a notable improvement from the C$0.89M net loss in the comparable prior period.
- Management highlighted the AMA brand maintaining top-5 positioning in Nevada, with flower ranking climbing to 1st and concentrates holding 2nd as of February 2026.
- Revenue and margin declines were attributed to falling wholesale flower prices, competition from illicit hemp-derived cannabinoids, and reduced Las Vegas tourism.
- The release points to anticipated federal regulatory changes in November 2026 that would redefine hemp and restrict psychoactive hemp-derived products, which management believes will benefit licensed Nevada operators.
Material Impact
- The Q2 results are a mixed but largely expected outcome. Top-line contraction and margin compression reflect persistent macro headwinds in the Nevada cannabis market, while the narrowed net loss is entirely a function of cost-cutting rather than operational growth.
- This release does not deviate from the trajectory established in Q1 FY2026, where the company achieved a small net profit through similar expense reductions. The reversion to a minor net loss in Q2 confirms that profitability remains fragile and highly dependent on overhead management rather than revenue expansion.
- The regulatory catalyst cited (November 2026 hemp redefinition) is a forward-looking industry-wide tailwind, not a company-specific near-term catalyst. It does not alter the immediate liquidity or operational reality.
- Given the stock's micro-cap valuation and extreme illiquidity, this earnings release lacks the surprise or scale required to move the share price materially. It is an incremental update that confirms ongoing survival-mode operations.
TGIF · Price
Company Overview
- 1933 Industries is a Nevada-focused cannabis operator engaged in cultivation, production, and wholesale distribution.
- Flagship project: Alternative Medicine Association (AMA) LLC, a 100% owned subsidiary operating a large-scale cultivation and production facility in Nevada.
- The company's strategy centers on wholesale brand positioning, with AMA consistently ranking in the top 5 for overall cannabis sales and top 3 for concentrates in the Nevada market.
- Operations are entirely domestic to Nevada, with no disclosed international assets or royalty-bearing properties. The facilities are assumed to be royalty-free, though heavy lease obligations function as a fixed cost burden.
More from 1933 Industries Inc.
Jun 29, 2026 · 17:47